ID   WFKN1_RAT               Reviewed;         552 AA.
AC   P0C5J5;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 1.
DT   02-OCT-2024, entry version 99.
DE   RecName: Full=WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1;
DE   Flags: Precursor;
GN   Name=Wfikkn1; Synonyms=Oc29;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=15497143; DOI=10.1002/dvdy.20180;
RA   Nishida A.T., Kobuke K., Kojima K., Ito J., Honjo T., Tashiro K.;
RT   "OC29 is preferentially expressed in the presumptive sensory organ region
RT   of the otocyst.";
RL   Dev. Dyn. 231:766-774(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
CC   -!- FUNCTION: Protease-inhibitor that contains multiple distinct protease
CC       inhibitor domains. Probably has serine protease- and metalloprotease-
CC       inhibitor activity (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Preferentially expressed in the developing inner
CC       ear and the dorsal neural tube. {ECO:0000269|PubMed:15497143}.
CC   -!- DEVELOPMENTAL STAGE: In the inner ear, it is first detectable at
CC       embryonic day 11.5 (11.5 dpc), broadly in the dorsolateral region of
CC       the otocyst, which gives rise to the vestibular organ. At 12.5 dpc, it
CC       becomes restricted to the presumptive sensory region, mainly to the
CC       BMP4-positive presumptive cristae, and expression becomes reduced at
CC       later stages. {ECO:0000269|PubMed:15497143}.
CC   -!- DOMAIN: The second BPTI/Kunitz inhibitor domain is able to inhibit
CC       trypsin. It has however no activity toward chymotrypsin, elastase,
CC       plasmin, pancreatic kallikrein, lung tryptase, plasma kallikrein,
CC       thrombin, urokinase or tissue plasminogen activator (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the WFIKKN family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03073234; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001123248.1; NM_001129776.1.
DR   AlphaFoldDB; P0C5J5; -.
DR   STRING; 10116.ENSRNOP00000056900; -.
DR   GlyCosmos; P0C5J5; 1 site, No reported glycans.
DR   GlyGen; P0C5J5; 1 site.
DR   PhosphoSitePlus; P0C5J5; -.
DR   PaxDb; 10116-ENSRNOP00000056900; -.
DR   GeneID; 363555; -.
DR   KEGG; rno:363555; -.
DR   UCSC; RGD:1565835; rat.
DR   AGR; RGD:1565835; -.
DR   CTD; 117166; -.
DR   RGD; 1565835; Wfikkn1.
DR   VEuPathDB; HostDB:ENSRNOG00000021578; -.
DR   eggNOG; KOG4597; Eukaryota.
DR   HOGENOM; CLU_037211_1_0_1; -.
DR   InParanoid; P0C5J5; -.
DR   OrthoDB; 5298642at2759; -.
DR   PhylomeDB; P0C5J5; -.
DR   TreeFam; TF315349; -.
DR   PRO; PR:P0C5J5; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000021578; Expressed in pancreas and 19 other cell types or tissues.
DR   GO; GO:0005576; C:extracellular region; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0048019; F:receptor antagonist activity; ISO:RGD.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0050431; F:transforming growth factor beta binding; ISO:RGD.
DR   GO; GO:0055001; P:muscle cell development; ISO:RGD.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0060021; P:roof of mouth development; ISO:RGD.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IBA:GO_Central.
DR   CDD; cd05765; IgI_3_WFIKKN-like; 1.
DR   CDD; cd00104; KAZAL_FS; 1.
DR   CDD; cd22606; Kunitz_WFIKKN_2-like; 1.
DR   Gene3D; 2.40.50.120; -; 1.
DR   Gene3D; 3.30.60.30; -; 1.
DR   Gene3D; 4.10.75.10; Elafin-like; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   Gene3D; 4.10.410.10; Pancreatic trypsin inhibitor Kunitz domain; 2.
DR   InterPro; IPR036645; Elafin-like_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR036058; Kazal_dom_sf.
DR   InterPro; IPR002223; Kunitz_BPTI.
DR   InterPro; IPR036880; Kunitz_BPTI_sf.
DR   InterPro; IPR001134; Netrin_domain.
DR   InterPro; IPR020901; Prtase_inh_Kunz-CS.
DR   InterPro; IPR008993; TIMP-like_OB-fold.
DR   InterPro; IPR008197; WAP_dom.
DR   InterPro; IPR033638; WFIKKN1/2_Ig-like_3.
DR   PANTHER; PTHR45938; ACP24A4-RELATED; 1.
DR   PANTHER; PTHR45938:SF6; WAP, KAZAL, IMMUNOGLOBULIN, KUNITZ AND NTR DOMAIN-CONTAINING PROTEIN 1; 1.
DR   Pfam; PF13927; Ig_3; 1.
DR   Pfam; PF00014; Kunitz_BPTI; 2.
DR   Pfam; PF00095; WAP; 1.
DR   PRINTS; PR00759; BASICPTASE.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SMART; SM00131; KU; 2.
DR   SMART; SM00217; WAP; 1.
DR   SUPFAM; SSF57362; BPTI-like; 2.
DR   SUPFAM; SSF57256; Elafin-like; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   SUPFAM; SSF100895; Kazal-type serine protease inhibitors; 1.
DR   SUPFAM; SSF50242; TIMP-like; 1.
DR   PROSITE; PS00280; BPTI_KUNITZ_1; 1.
DR   PROSITE; PS50279; BPTI_KUNITZ_2; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS51465; KAZAL_2; 1.
DR   PROSITE; PS50189; NTR; 1.
DR   PROSITE; PS51390; WAP; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain;
KW   Metalloenzyme inhibitor; Metalloprotease inhibitor; Protease inhibitor;
KW   Reference proteome; Repeat; Secreted; Serine protease inhibitor; Signal.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..552
FT                   /note="WAP, Kazal, immunoglobulin, Kunitz and NTR domain-
FT                   containing protein 1"
FT                   /id="PRO_0000307818"
FT   DOMAIN          29..82
FT                   /note="WAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00722"
FT   DOMAIN          112..163
FT                   /note="Kazal-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DOMAIN          190..283
FT                   /note="Ig-like C2-type"
FT   DOMAIN          289..355
FT                   /note="BPTI/Kunitz inhibitor 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DOMAIN          363..413
FT                   /note="BPTI/Kunitz inhibitor 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DOMAIN          413..544
FT                   /note="NTR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00295"
FT   SITE            126..127
FT                   /note="Reactive bond"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   CARBOHYD        497
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        36..69
FT                   /evidence="ECO:0000250"
FT   DISULFID        52..73
FT                   /evidence="ECO:0000250"
FT   DISULFID        56..68
FT                   /evidence="ECO:0000250"
FT   DISULFID        62..78
FT                   /evidence="ECO:0000250"
FT   DISULFID        120..150
FT                   /evidence="ECO:0000250"
FT   DISULFID        124..143
FT                   /evidence="ECO:0000250"
FT   DISULFID        132..161
FT                   /evidence="ECO:0000250"
FT   DISULFID        211..267
FT                   /evidence="ECO:0000250"
FT   DISULFID        303..355
FT                   /evidence="ECO:0000250"
FT   DISULFID        310..338
FT                   /evidence="ECO:0000250"
FT   DISULFID        330..351
FT                   /evidence="ECO:0000250"
FT   DISULFID        363..413
FT                   /evidence="ECO:0000250"
FT   DISULFID        372..396
FT                   /evidence="ECO:0000250"
FT   DISULFID        388..409
FT                   /evidence="ECO:0000250"
FT   DISULFID        421..493
FT                   /evidence="ECO:0000250"
FT   DISULFID        424..495
FT                   /evidence="ECO:0000250"
FT   DISULFID        435..544
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   552 AA;  59915 MW;  6CB7A90E8F3ADBC9 CRC64;
     MPAPQPLLPL LFAFVLIHLT SETNLLPEPG SHPGMCPNQL SPHLWVDAQS TCERECTRDQ
     DCAASEKCCT NVCGLQSCVA ARFPSGGPAT PETAASCEDF QCPQQGSNCD IWDGQPVCRC
     RDRCEKEPSF TCASDGLTYY NRCYMDAEAC LRGLHLHVVP CKHILSWPPS SPGPPETTAR
     PTPGAAPMPP ALYNSPSPQA VHVGGTASLH CDVSGRPPPA VTWEKQSHQR ENLIMRPDQM
     YGNVVVTSIG QLVLYNAQLE DAGLYTCTAR NAAGLLRADF PLSVLQRATT QDRDPGVLAL
     AECQPDTQAC VGPPTPHHVL WRFDPQRGSC MTFPALKCDG AARGFETYEA CQQACVRGPG
     DVCALPPVQG PCQGWEPRWA YSPLLQQCHP FIYSGCEGNS NNFESRESCE DACPVPRTPP
     CRACRLKSKL ALSLCRSDFA IVGRLTEVLE EPEAAGGIAR VALDDVLKDD KMGLKFLGTK
     YLEVTLSGMD WACPCPNVTV GDGPLVIMGE VREGVAVLDA NSYVRAASEK RVKKIVELLE
     KKACELLNRF QD
//
